The researchers hope the breakthrough will help scientists cure a genetic disorder that increases the likelihood of dying from coronary artery disease at a young age.
Pharmacy benefits manager CVS Health has warned that the new PCSK9 inhibitor class of cholesterol-lowering drugs poses an unprecedented challenge to the US healthcare system. In a blog post ...
Amgen, Sanofi and Regeneron have been forced to cut the cost of their new cholesterol drugs in negotiations with America's most powerful healthcare gatekeeper. Express Scripts, the largest manager ...
Two new drugs will soon be available to target little-known forms of high cholesterol, which are driven by our genes and which so far have lacked treatment options. Two clinical trials involving ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...